<![CDATA[TriLink BioTechnologies 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=43252>Mon, 06 Apr 2026 00:31:29 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines]]>https://www.newswire.co.kr/newsRead.php?no=1011235Thu, 15 May 2025 16:30:00 +0900<![CDATA[TriLink BioTechnologies®-국제백신연구소, mRNA 기반 백신 개발 지원 양해각서 체결]]>https://www.newswire.co.kr/newsRead.php?no=1011238Thu, 15 May 2025 16:30:00 +0900<![CDATA[TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion]]>https://www.newswire.co.kr/newsRead.php?no=967565Thu, 25 May 2023 11:30:00 +0900<![CDATA[트라이링크 바이오테크놀로지®, mRNA 제조 시설 완공이 가까워짐에 따라 제조 능력 확장 발표]]>https://www.newswire.co.kr/newsRead.php?no=967567Thu, 25 May 2023 11:30:00 +0900